Clinical trial
Combination Corticosteroids + 5-aminosalicylic Acids Compared to Corticosteroids Alone in the Treatment of Moderate-severe Active Ulcerative Colitis.
NCT01941589 is registered in ClinicalTrials.gov with Sheba Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Combination Corticosteroids + 5-aminosalicylic Acids Compared to Corticosteroids Alone in the Treatment of Moderate-severe Active Ulcerative Colitis.
- Lead sponsor
- Sheba Medical Center
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- September 30, 2013
- Completion date
- April 30, 2021
- Enrollment
- 149 (actual)
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.
ulcerative colitis